Redo mitral valve surgery 15 years after bioprosthetic valve implantation in a patient with hepatic and cardiac comorbidities

Omar S. Khan; Sharmin Jahan; Rezwanul Haque; Sumit Barua; Mostafa Nuruzzaman

doi:10.18203/2320-6012.ijrms20253627

Authors

Omar S. Khan Department of Cardiac Surgery, Bangladesh Medical University, Dhaka, Bangladesh
Sharmin Jahan Department of Cardiac Surgery, Bangladesh Medical University, Dhaka, Bangladesh
Rezwanul Haque Department of Cardiac Surgery, Bangladesh Medical University, Dhaka, Bangladesh
Sumit Barua Department of Cardiac Surgery, Bangladesh Medical University, Dhaka, Bangladesh
Mostafa Nuruzzaman Department of Anaesthesiology, Bangladesh Medical University, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20253627

Keywords:

Redo mitral valve replacement, Femoro-femoral cardiopulmonary bypass, Structural valve deterioration

Abstract

Redo mitral valve surgery poses significant technical and clinical challenges, especially in patients having a third reoperation. These cases are associated with increased operative threat due to adhesions, previous sternotomies, and limited surgical exposure. With significant advancements in surgical techniques, perioperative care, and patient selection, successful outcomes can still be achieved. We report the case of a 47-year-old male with a complex cardiac history, including surgical atrial septal defect (ASD) closure and prior bioprosthetic mitral valve replacements, who presented with symptomatic structural valve deterioration and progressive heart failure. A third-time redo mitral valve replacement was performed via median sternotomy, using femoral cannulation. Intraoperative findings included extensive adhesions and prior prosthetic valve degeneration. The postoperative course was notable for transient low cardiac output and arrhythmia management; however, the patient eventually recovered well and was discharged on the 10th postoperative day.

Metrics

Metrics Loading ...

References

Capodanno D, Petronio AS, Prendergast B, Eltchaninoff H, Vahanian A, Modine T, et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves. Eur J Cardiothorac Surg. 2017;52:408-17. DOI: https://doi.org/10.1093/ejcts/ezx244

Dvir D, Bourguignon T, Otto CM, Hahn RT, Rosenhek R, Webb JG, et al. Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves. Circulation. 2018;137:388-99. DOI: https://doi.org/10.1161/CIRCULATIONAHA.117.030729

Kostyunin AE, Yuzhalin AE, Rezvova MA, Ovcharenko EA, Glushkova TV, Kutikhin AG. Degeneration of bioprosthetic heart valves: update 2020. J Am Heart Assoc. 2020;9(19):e018506. DOI: https://doi.org/10.1161/JAHA.120.018506

Yu J, Qiao E, Wang W. Mechanical or biologic prostheses for mitral valve replacement: a systematic review and meta-analysis. Clin Cardiol. 2022;45(7):701-16. DOI: https://doi.org/10.1002/clc.23854

Bourguignon T, Bouquiaux-Stablo AL, Candolfi P, Mirza A, Loardi C, May MA, et al. Very long-term outcomes of the Carpentier-Edwards Perimount valve in the mitral position. Ann Thorac Surg. 2015;99(3):831-7. DOI: https://doi.org/10.1016/j.athoracsur.2014.09.030

Gammie JS, Sheng S, Griffith BP, Peterson ED, Rankin JS. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg. 2009;87(5):1431-7. DOI: https://doi.org/10.1016/j.athoracsur.2009.01.064

Abdelgawad E, Ahmed AM, Abdelaziz A. Redo-mitral valve replacement and predictors of operative mortality: a single-institute experience. J Med Sci Res. 2021;4(1):6. DOI: https://doi.org/10.4103/JMISR.JMISR_61_20

Belluschi I, Buzzatti N, Castiglioni A, De Bonis M, Maisano F, Alfieri O. Aortic and mitral bioprosthetic valve dysfunction: surgical or percutaneous solutions? Eur Heart J Suppl. 2021;23(Suppl E):E6-12. DOI: https://doi.org/10.1093/eurheartj/suab083

Steppan J, Heerdt PM. Preoperative assessment and perioperative management of the patient with pulmonary vascular disease. Clin Chest Med. 2021;42(1):133-41. DOI: https://doi.org/10.1016/j.ccm.2020.11.013

Luciani N, Anselmi A, De Geest R, Martinelli L, Perisano M, Possati G. Extracorporeal circulation by peripheral cannulation before redo sternotomy: indications and results. J Thorac Cardiovasc Surg. 2008;136(3):572-7. DOI: https://doi.org/10.1016/j.jtcvs.2008.02.071

Bouhout I, El-Hamamsy I. The PROACT trial: lower is better, but is it good enough? Glob Cardiol Sci Pract. 2019;2019(1):2. DOI: https://doi.org/10.21542/gcsp.2019.2

Lomivorotov VV, Efremov SM, Kirov MY, Fominskiy EV, Karaskov AM. Low-Cardiac-Output Syndrome After Cardiac Surgery. J Cardiothorac Vasc Anesth. 2017;31(1):291-308. DOI: https://doi.org/10.1053/j.jvca.2016.05.029